Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar

Journal article

Kyaw SS. et al, (2021), BMC Public Health, 21

Multiphase evaluation of portable medicines quality screening devices

Journal article

Caillet C. et al, (2021), PLOS Neglected Tropical Diseases, 15, e0009287 - e0009287

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study

Journal article

Devine A. et al, (2021), PLOS Medicine, 18, e1003614 - e1003614

Point-of-care C-reactive protein testing and antibiotic prescribing.

Journal article

Althaus T. et al, (2021), The Lancet. Global health, 9

Causes of fever in primary care in Southeast Asia and the performance of C-reactive protein in discriminating bacterial from viral pathogens

Journal article

Althaus T. et al, (2020), International Journal of Infectious Diseases, 96, 334 - 342

Determinants of MDA impact and designing MDAs towards malaria elimination

Journal article

Gao B. et al, (2020), eLife, 9

Sensitivity of C‐reactive protein for the identification of patients with laboratory‐confirmed bacterial infections in northern Tanzania

Journal article

Althaus T. et al, (2020), Tropical Medicine & International Health, 25, 291 - 300

Prevalence of Group A Streptococcus in Primary Care Patients and the Utility of C-Reactive Protein and Clinical Scores for Its Identification in Thailand

Journal article

Greer R. et al, (2020), The American Journal of Tropical Medicine and Hygiene, 102, 377 - 383

Load More